Concepedia

Megan L. Noonan

ML

Statistics

Publications

11

Citations

393

H-Index

11

Active since

2015

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Indiana University School of Medicine

The University of Adelaide

Indiana University Indianapolis

Indiana University Health

Megan L. Noonan is an author at Indiana University – Purdue University Indianapolis specializing in medicine, fibroblast growth factor 23 dysregulation, and bone metabolism.

ORCID

Publications per year

2015–2023

11

Publications

11

WNT1-induced Secreted Protein-1 (WISP1), a Novel Regulator of Bone Turnover and Wnt Signaling

Azusa Maeda, Mitsuaki Ono, Kenn Holmbeck et al. · Journal of Biological Chemistry · 2015 · 96 citations · Full text

, , +16

Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD

Erica L. Clinkenbeard, Megan L. Noonan, Joseph C. Thomas et al. · JCI Insight · 2019 · 70 citations · Full text

, , +17

Erythropoietin and a hypoxia‐inducible factor prolyl hydroxylase inhibitor (HIF‐PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)

Megan L. Noonan, Erica L. Clinkenbeard, Pu Ni et al. · Physiological Reports · 2020 · 54 citations · Full text

, , +16

The HIF-PHI BAY 85-3934 (Molidustat) Improves Anemia and Is Associated With Reduced Levels of Circulating FGF23 in a CKD Mouse Model

Megan L. Noonan, Pu Ni, Rafiou Agoro et al. · Journal of Bone and Mineral Research · 2020 · 30 citations · Full text

, , +16

Single cell cortical bone transcriptomics define novel osteolineage gene sets altered in chronic kidney disease

Rafiou Agoro, Intawat Nookaew, Megan L. Noonan et al. · Frontiers in Endocrinology · 2023 · 29 citations · Full text

, , +16

1–5 of 11